( December 12, 2024, 12:09 PM EST) -- WASHINGTON, D.C. — A medical device company that told the U.S. Supreme Court that the Federal Circuit U.S. Court of Appeals inappropriately expanded a safe harbor found in the Patent Act waived its right to a 14-day waiting period after an upcoming requested filing from the respondent medical company in the case, arguing that the case should be distributed for the high court’s Jan. 10 conference....